Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

[Sleep and nocturnal incontinence in hospital or institutional care].

Walk E, Schwartz C, Hidot N, Mazin V, Pochon S, Renaux-Bouttier V, Guyon A, Greusard C, Wenger I.

Soins Gerontol. 2017 Jul - Aug;22(126):41-44. doi: 10.1016/j.sger.2017.05.008. Review. French.

PMID:
28687132
2.

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.

Vyberg M, Nielsen S, Røge R, Sheppard B, Ranger-Moore J, Walk E, Gartemann J, Rohr UP, Teichgräber V.

BMC Health Serv Res. 2015 Aug 29;15:352. doi: 10.1186/s12913-015-1018-6.

3.

High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes.

Walk EL, McLaughlin SL, Weed SA.

J Vis Exp. 2015 Jul 25;(101):e52718. doi: 10.3791/52718.

4.

Use of high frequency ultrasound to monitor cervical lymph node alterations in mice.

Walk EL, McLaughlin S, Coad J, Weed SA.

PLoS One. 2014 Jun 23;9(6):e100185. doi: 10.1371/journal.pone.0100185. eCollection 2014.

5.

Commercially available blood-group antibodies may be used to visualize blood group A antigen in paraffin-embedded tissue sections.

Gehrie E, Muranyi A, Walk E, Young PP.

Arch Pathol Lab Med. 2014 Feb;138(2):155. doi: 10.5858/arpa.2013-0302-LE. No abstract available.

PMID:
24476512
6.

Patient safety and cancer: the dialogue begins on Capitol Hill.

Walk E.

MLO Med Lab Obs. 2013 May;45(5):66. No abstract available.

PMID:
23763054
7.

Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop.

Hayes KE, Walk EL, Ammer AG, Kelley LC, Martin KH, Weed SA.

Oncogene. 2013 Oct;32(40):4766-77. doi: 10.1038/onc.2012.513. Epub 2012 Nov 12.

8.

Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: a phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788.

Baselga J, Mita AC, Schöffski P, Dumez H, Rojo F, Tabernero J, DiLea C, Mietlowski W, Low C, Huang J, Dugan M, Parker K, Walk E, van Oosterom A, Martinelli E, Takimoto CH.

Clin Cancer Res. 2012 Nov 15;18(22):6364-72. doi: 10.1158/1078-0432.CCR-12-1499. Epub 2012 Sep 26.

9.

Quantitative measurement of invadopodia-mediated extracellular matrix proteolysis in single and multicellular contexts.

Martin KH, Hayes KE, Walk EL, Ammer AG, Markwell SM, Weed SA.

J Vis Exp. 2012 Aug 27;(66):e4119. doi: 10.3791/4119.

10.

Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma.

Walk EL, Weed SA.

Cancers (Basel). 2011 Feb 22;3(1):747-72. doi: 10.3390/cancers3010747.

11.

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.

Walk EE.

Curr Opin Drug Discov Devel. 2010 Mar;13(2):226-34. Review.

PMID:
20205056
12.

The role of pathologists in the era of personalized medicine.

Walk EE.

Arch Pathol Lab Med. 2009 Apr;133(4):605-10. doi: 10.1043/1543-2165-133.4.605. No abstract available.

PMID:
19391660
13.

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).

Nitta H, Hauss-Wegrzyniak B, Lehrkamp M, Murillo AE, Gaire F, Farrell M, Walk E, Penault-Llorca F, Kurosumi M, Dietel M, Wang L, Loftus M, Pettay J, Tubbs RR, Grogan TM.

Diagn Pathol. 2008 Oct 22;3:41. doi: 10.1186/1746-1596-3-41.

14.

The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.

Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.

J Urol. 2008 Feb;179(2):508-11; discussion 511-2.

PMID:
18076912
15.

CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease.

Woodson K, O'Reilly KJ, Ward DE, Walter J, Hanson J, Walk EL, Tangrea JA.

Epigenetics. 2006 Oct-Dec;1(4):183-6. Epub 2006 Oct 24.

PMID:
17998819
16.

Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma.

Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ; National Osteosarcoma Etiology Study Group.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1667-74.

17.

[Quality of sleep and management of nocturnal continence in the elderly in the hospital or institution].

Kehlhoffner M, Sadorge T, Malet J, Mazin V, Toussaint N, Walk E.

Soins Gerontol. 2005 Jul-Aug;(54):38. French. No abstract available.

PMID:
16106693
18.

Architectural barriers to persons with disabilities in businesses in an urban community.

Ahn HC, McGovern EE, Walk EE, Edlich RF.

J Burn Care Rehabil. 1994 Mar-Apr;15(2):175-9.

PMID:
8195261
19.

Americans With Disabilities Act.

Walk EE, Ahn HC, Lampkin PM, Nabizadeh SA, Edlich RF.

J Burn Care Rehabil. 1993 Jan-Feb;14(1):92-8. Review.

PMID:
8454675
20.

Personal emergency response systems.

Redd JL, Zura RD, Tanner AE, Walk EE, Wu MM, Edlich RF.

J Burn Care Rehabil. 1992 Jul-Aug;13(4):453-9. Review.

PMID:
1429819

Supplemental Content

Support Center